Bevacizumab in Recurrent Grade II and III Glioma (Q63833350)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bevacizumab in Recurrent Grade II and III Glioma |
clinical trial |
Statements
TAVAREC (English)
0 references
Randomized Trial Assessing the Significance of Bevacizumab in Recurrent Grade II and Grade III Gliomas - The TAVAREC Trial (English)
0 references
February 2011
0 references
19 January 2017
0 references
155
0 references
18 year
0 references